Phosphate → (5R)-3-(6-{2-[(4-aminobenzyl)oxy]ethoxy}hexyl)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one
反応式
[CH3:1][C:2]1([CH3:49])[O:7][C:6]2[CH:8]=[CH:9][C:10]([C@H:12]3[O:16][C:15](=[O:17])[N:14]([CH2:18][CH2:19][CH2:20][CH2:21][CH2:22][CH2:23][O:24][CH2:25][CH2:26][O:27][CH2:28][C:29]4[CH:34]=[CH:33][C:32]([N:35]=C(C5C=CC=CC=5)C5C=CC=CC=5)=[CH:31][CH:30]=4)[CH2:13]3)=[CH:11][C:5]=2[CH2:4][O:3]1.C([O-])(=O)C.[Na+].Cl.NO.P([O-])([O-])([O-])=O>CO>[NH2:35][C:32]1[CH:31]=[CH:30][C:29]([CH2:28][O:27][CH2:26][CH2:25][O:24][CH2:23][CH2:22][CH2:21][CH2:20][CH2:19][CH2:18][N:14]2[CH2:13][C@@H:12]([C:10]3[CH:9]=[CH:8][C:6]4[O:7][C:2]([CH3:1])([CH3:49])[O:3][CH2:4][C:5]=4[CH:11]=3)[O:16][C:15]2=[O:17])=[CH:34][CH:33]=1参加物
6
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
A solution of (5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-3-{6-[2-({4-[(diphenylmethylene)amino]benzyl}oxy)ethoxy]hexyl}-1,3-oxazolidin-2-one (860 mg) in MeOH (13 ml) was treated with sodium acetate (255 mg) followed by hydroxylamine hydrochloride (162 mg) and the mixture was stirred at 20° for 0.5 h. Phosphate buffer solution (30 ml, pH6.5) was added and the mixture was extracted with EtOAc. The combined extracts were dried (Na2SO4) and the solvent evaporated in vacuo. The residue was purified by SPE (silica, 10 g). Elution with EtOAc-cyclohexane (1:1) then (4:1) gave the title compound (321 mg). LCMS RT=3.18 min.
後処理
- extractionthe mixture was extracted with EtOAc
- dry with materialThe combined extracts were dried (Na2SO4)
- customthe solvent evaporated in vacuo
- customThe residue was purified by SPE (silica, 10 g)
- washElution with EtOAc-cyclohexane (1:1)
出典と根拠
- ORDレコード
- ord-34faa6be1dc44ee7a6c677e074312865
- 出典データセット
- uspto-grants-2012_06
- 特許番号
- US08198483B2
反応ノート
読み込み中…